Search research articles
Contact Us
Filters
Showing results (81-90 of 144) with videos related to
Page
of 15
Sort By:
Nature
|
February 15, 2023
Evidence for Dirac flat band superconductivity enabled by quantum geometry
Haidong Tian, Xueshi Gao, Yuxin Zhang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program
David Guy, Gabriella Ghanem, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2010
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer
Gerard C Morton, D Andrew Loblaw, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 20, 2011
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
Gerard Morton, Andrew Loblaw, Patrick Cheung, et al.
The Lancet. Oncology
|
January 21, 2014
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study
Robert K Nam, Patrick Cheung, Sender Herschorn, et al.
The Lancet. Diabetes & Endocrinology
|
May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study
Christopher J D Wallis, Kirk Lo, Yuna Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial
Mark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 9, 2020
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton, Merrylee McGuffin, Hans T Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2018
Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy
Srinivas Raman, Lee Chin, Darby Erler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 9, 2016
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
Gerard Morton, Hans T Chung, Merrylee McGuffin, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 144) with videos related to
Sort By:
Page
of 15
Nature
|
February 15, 2023
Evidence for Dirac flat band superconductivity enabled by quantum geometry
Haidong Tian, Xueshi Gao, Yuxin Zhang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program
David Guy, Gabriella Ghanem, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2010
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer
Gerard C Morton, D Andrew Loblaw, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 20, 2011
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
Gerard Morton, Andrew Loblaw, Patrick Cheung, et al.
The Lancet. Oncology
|
January 21, 2014
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study
Robert K Nam, Patrick Cheung, Sender Herschorn, et al.
The Lancet. Diabetes & Endocrinology
|
May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study
Christopher J D Wallis, Kirk Lo, Yuna Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 28, 2020
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial
Mark Corkum, Andrew Loblaw, Yaser Hasan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 9, 2020
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton, Merrylee McGuffin, Hans T Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2018
Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy
Srinivas Raman, Lee Chin, Darby Erler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 9, 2016
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
Gerard Morton, Hans T Chung, Merrylee McGuffin, et al.
Page
of 15